The DEA has backed off of a quota-setting policy that hospitals and drug makers said would’ve created shortages of morphine and other opioids that hospitals commonly administer. statnews.com/2024/05/01/dea…

In major win for the Biden Admin, federal judge in NJ rejects multiple constitutional claims by drug companies seeking to block Medicare drug negotiation. First time a court has directly ruled on Takings Clause argument, at heart of lawsuits brought by numerous companies.

The legal arguments against the Inflation Reduction Act are, uh, not going so well, Rachel Cohrs Zhang reports.

statnews.com/2024/04/29/fed…

Takeda is the fourth big company to leave BIO since December. It joins Pfizer, UCB and WuXi, though WuXi was an unusual situation. statnews.com/2024/04/24/tak…

D.C. folks! Come hang with STAT on April 29 for an evening of discussion around policy in health care this election year. Speakers and agenda here:
statnews.com/event/stat-in-…

An incredible honor for STAT reporters.
'STAT made a difference in the lives of patients across the nation by having the courage to pursue such a difficult story and the compassion to help those who were so callously treated by the nation’s largest health insurer.''

There have been a lot of changes around here — a new byline after getting married last month, and now a new job title! I am very excited to take on more responsibility to support our incredible STAT D.C. team.
statnews.com/new-leadership…

Huge congratulations to Casey Ross Bob Herman for winning the coveted 2024 NIHCM Award for Investigative and General Reporting for their eye-opening series, 'Denied by AI: Consequences for Sick and Vulnerable Americans.''

STAT won another NIHCM Award!

My colleagues Bob Herman and Casey Ross are winners of the 2024 NIHCM Investigative and General Reporting Award for a series of stories showing how insurers use AI to deny care to sick Americans.

nihcm.org/awards/winners…

This is STAT's third…

Senate Majority Leader Chuck Schumer promised two years ago to hold a vote on a bill to ensure people with all types of insurance have access to $35/month insulin. He hasn't done it.

I dug into the counterintuitive dynamics that have led to a stalemate statnews.com/2024/04/16/chu…

Rep. McMorris-Rogers says at House healthcare cybersecurity hearing that #UnitedHealth failed to make anyone available to testify about the #ChangeHealthcare #cyberattack

but did brief E&C members recently and promised to testify at a future hearing

Follow Elaine Chen as she takes on a broader beat covering the biotech industry after absolutely crushing STAT's coverage of weight-loss drugs!

The Arizona Supreme Court shook up the national abortion debate this week, ruling that a ban originally passed in 1864 could be enforced. Host julie rovner and panelists Alice Miranda Ollstein, Rachel Cohrs Zhang, & Rachel Roubein discuss the ruling and more on #WTHealth : kffhealthnews.org/news/podcast/w…

Medicare expects to spend $3.5 billion on the Alzheimer's treatment Leqembi in 2025 — well beyond what Wall Street or even the drug's manufacturer has projected. Read more from Rachel Cohrs Zhang and me: statnews.com/2024/04/11/med…

More tumult at BIO: The group's top lobbyist exits suddenly, and its new CEO signals that more changes may be on the way statnews.com/2024/04/10/bio…

The exit of BIO's top lobbyist might be part of a larger shakeup under the trade group's new CEO John Crowley. By Rachel Cohrs Zhang and me. statnews.com/2024/04/10/bio…

News: Health and Human Services Secretary Xavier Becerra is weighing his exit from the Biden administration — likely after the November election — to run for California governor in 2026.

w/ Dustin Gardiner Adam Cancryn

politico.com/news/2024/04/0…

Hospitals must report charity care to the government and their investors / bondholders. But charity care numbers are not always the same — and in some cases are way off. Tara Bannow did some digging and found big inconsistencies at HCA and elsewhere. statnews.com/2024/04/08/hca…

Boehringer Ingelheim layoffs are a sign of dysfunctional Humira biosimilar market statnews.com/2024/04/04/boe… via John Wilkerson

The market is so dysfunctional that Boehringer Ingelheim already is laying off or relocating the sales force for its Humira biosimilar. statnews.com/2024/04/04/boe…